Telesis Bio Q4 EPS $(0.61) Misses $(0.22) Estimate, Sales $6.98M Miss $7.00M Estimate
Telesis Bio Q4 EPS $(0.61) Misses $(0.22) Estimate, Sales $6.98M Miss $7.00M Estimate
Telesis Bio第四季度每股收益美元（0.61美元）未达到预期（0.22美元），销售额为698万美元，未达到700万美元的预期
Telesis Bio (NASDAQ:TBIO) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.22) by 177.27 percent. This is a 117.86 percent decrease over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $6.98 million which missed the analyst consensus estimate of $7.00 million by 0.33 percent. This is a 26.32 percent decrease over sales of $9.47 million the same period last year.
Telesis Bio（纳斯达克股票代码：TBIO）公布的季度亏损为每股0.61美元，比分析师普遍预期的0.22美元（0.22美元）低177.27％。与去年同期每股亏损0.28美元（0.28）相比，下降了117.86％。该公司公布的季度销售额为698万美元，比分析师普遍预期的700万美元低0.33％。这比去年同期的947万美元销售额下降了26.32％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。